Polycystic ovary syndrome and infertility

被引：1

作者：

Sofia Vanhauwaert, Paula ^{[1
,2
,3
]}

机构：

[1] Univ Santiago Chile, Dept Ginecol & Obstetricia, Santiago, Chile

[2] Clin Alemana Santiago, Unidad Endocrinol Ginecol, Santiago, Chile

[3] Soc Chilena Endocrinol Ginecol, Santiago, Chile

来源：

REVISTA MEDICA CLINICA LAS CONDES | 2021年 / 32卷 / 02期

关键词：

Polycystic Ovary Syndrome; Infertility; Hyperandrogenism; Anovulation; Insulin Resistance; ANTI-MULLERIAN HORMONE; REPRODUCTIVE OUTCOMES; LUTEINIZING-HORMONE; DIAGNOSTIC-CRITERIA; ANOVULATORY WOMEN; IN-VITRO; EXPRESSION; RELEVANCE; PREGNANCY; PITUITARY;

D O I：

10.1016/j.rmclc.2020.11.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Infertility is one of the main manifestations of the polycystic ovary syndrome (PCOS), and to day PCOS is the main cause of anovulatory infertility accounting for 80% of the cases. The majority of PCOS causes of infertility are treatable, and early diagnosis improves the patient's fertility outcome. In spite of its incidence and importance, the physiopathological mechanisms of PCOS are still relatively unknown. Recently an international evidence base recommendation for treatment have been published.

引用

页码：166 / 172

页数：7

共 50 条

[21] The treatment of infertility in polycystic ovary syndrome: a brief update
Costello, Michael F.
Misso, Marie L.
Wong, Jennifer
Hart, Roger
Rombauts, Luk
Melder, Angela
Norman, Robert J.
Teede, Helena J.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2012, 52 (04) : 400 - 403
[22] Unravelling Polycystic Ovary Syndrome and Its Comorbidities
Kim, Kyung-Wook
JOURNAL OF OBESITY & METABOLIC SYNDROME, 2021, 30 (03) : 209 - 221
[23] Polycystic Ovary Syndrome: A Contemporary Clinical Approach
Bjekic-Macut, Jelica
Vukasin, Tamara
Velija-Asimi, Zelija
Burekovic, Azra
Zdravkovic, Marija
Andric, Zoran
Brankovic, Marija
Crevar-Marinovic, Slobodanka
Madic, Tatjana
Stanojlovic, Olivera
Milutinovic, Danijela, V
Livadas, Sarantis
Mastorakos, George
CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (36) : 3812 - 3820
[24] Incorporating patient preference into the management of infertility in women with polycystic ovary syndrome
Okoroafor, Ugochi C.
Jungheim, Emily S.
PATIENT PREFERENCE AND ADHERENCE, 2012, 6 : 407 - 415
[25] Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome
Chen, Zhuo
Ou, Hanxiao
Wu, Hongliang
Wu, Peng
Mo, Zhongcheng
DNA AND CELL BIOLOGY, 2019, 38 (08) : 754 - 762
[26] Steroidogenesis in polycystic ovary syndrome
Ventura-Arizmendi, Estefania
Hernandez-Valencia, Marcelino
GACETA MEDICA DE MEXICO, 2019, 155 (02): : 184 - 190
[27] Polycystic Ovary Syndrome in Adolescents
Saleh, Farrah L.
Starkman, Hava
Furness, Allison
Pfeifer, Samantha M.
Kives, Sari
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2024, 51 (04) : 679 - 693
[28] Quercetin and polycystic ovary syndrome
Ma, Congshun
Xiang, Qianru
Song, Ge
Wang, Xuefei
FRONTIERS IN PHARMACOLOGY, 2022, 13
[29] The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?
Wang, Rui
Mol, Ben Willem J.
HUMAN REPRODUCTION, 2017, 32 (02) : 261 - 264
[30] Role of Anti-Mullerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
Dewailly, Didier
Barbotin, Anne-Laure
Dumont, Agathe
Catteau-Jonard, Sophie
Robin, Geoffroy
FRONTIERS IN ENDOCRINOLOGY, 2020, 11

← 1 2 3 4 5 →